Discussion on the identification and legal application of “counterfeit and substandard drugs” in China's new “Drug Administration Law”

ZHOU Jing-jing, TAN Zai-xiang

Soft Science of Health ›› 2022, Vol. 36 ›› Issue (2) : 68-71.

PDF(759 KB)
PDF(759 KB)
Soft Science of Health ›› 2022, Vol. 36 ›› Issue (2) : 68-71. DOI: 10.3969/j.issn.1003-2800.2022.02.014

Discussion on the identification and legal application of “counterfeit and substandard drugs” in China's new “Drug Administration Law”

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(2): 68-71 https://doi.org/10.3969/j.issn.1003-2800.2022.02.014

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(759 KB)

Accesses

Citation

Detail

Sections
Recommended

/